The authors describe a cell-based assay for anti-microtubule compounds suitable for automation. This assay allows the identification, in a single screening campaign, of both microtubule-destabilizing and microtubule-stabilizing agents. Its rationale is based on the substrate properties of the tubulin-modifying enzymes involved in the tubulin tyrosination cycle. This cycle involves the removal of the C-terminal tyrosine of the tubulin α-subunit by an ill-defined tubulin carboxypeptidase and its readdition by tubulin tyrosine ligase. Because of the substrate properties of these enzymes, dynamic microtubules, sensitive to depolymerizing drugs, are composed of tyrosinated tubulin, whereas nondynamic, stabilized microtubules are composed of detyrosinated tubulin. Thus depolymerization or stabilization of the microtubule network can easily be detected with doubleimmunofluorescence staining using antibodies specific to tyrosinated and detyrosinated tubulin. The authors have scaled this assay to the 96-well plate format and adapted its process for an automated handling, including a readout using a microplate reader. They describe the different steps of this adaptation. This assay was validated using known compounds. This new cellbased assay represents an alternative to both global cytotoxicity assays and in vitro tubulin assembly assays commonly used for the detection of microtubule poisons. (Journal of Biomolecular Screening 2006:377-389) Journal of Biomolecular Screening 11(4); 2006 www.sbsonline.org 381 FIG. 3. Comparison of the effect of several fixation techniques on the integrity of the microtubular network. HeLa cells grown on coverslips were fixed either at -20°C with methanol (A) or at room temperature with methanol (B) or with formaldehyde 3.7% (C). They were then processed for Tyr-tubulin immunofluorescence as described in the "Materials and Methods" section. Journal of Biomolecular Screening 11(4); 2006 www.sbsonline.org 385 FIG. 9.
INTRODUCTION
M ICROTUBULES ARE KEY COMPONENTS of the cytoskeleton of eukaryotic cells. They are long, filamentous, tube-shaped protein polymers. They are crucial for the development and maintenance of cell shape, intracellular organelle, and other components of transport, cell signaling, and mitosis. Their central role in mitosis and cell division makes microtubules an important target for anticancer drugs. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] In addition to cancer, the microtubular cytoskeleton has been implicated in the etiology of a wide variety of diseases including neurodegenerative and mental diseases, [13] [14] [15] viral infections, [16] [17] [18] and parasitic diseases. [19] [20] [21] [22] [23] [24] Therefore, pharmaceuticals that target microtubules may have wide clinical applications. Moreover, compounds targeting the microtubular cytoskeleton have proven to be valuable tools for basic research in cell biology. 25 Microtubules are cylindrical aggregates of α-tubulin and βtubulin heterodimers. They are highly dynamic polymers, and their polymerization dynamics are tightly regulated both in space and time. Microtubules' various biological functions are determined and regulated in large part by their polymerization dynamics. 26 Cancer drugs such as paclitaxel or Vinca alkaloids were previously thought to work through opposite mechanisms. They are now known to act by modifying microtubule dynamics and not through increasing or decreasing the overall microtubule mass. 1 We have developed and robotized a new cell-based assay, which allows the identification, in a single screening campaign, of both microtubule-destabilizing and microtubule-stabilizing agents. The rationale of this assay is based on the substrate properties of the tubulin-modifying enzymes involved in the tubulin tyrosination cycle.
The tubulin tyrosination cycle
The tubulin tyrosination cycle was discovered some 30 years ago. 27, 28 It involves the cyclic removal of the carboxy-terminal tyrosine residue of the α-tubulin chain by an uncharacterized tubulin carboxypeptidase (TCP) and the readdition of a tyrosine residue at the same location by tubulin tyrosine ligase (TTL), in an ATPdependent reaction [29] [30] [31] (Fig. 1) . In most α-tubulins, the carboxyterminal tyrosine is encoded for by messenger RNA. Thus, the primary modification is the tyrosine removal by TCP. The resulting detyrosinated tubulin exposes a carboxy-terminal glutamic acid and is therefore referred to as Glu-tubulin. Tubulin tyrosination is known to occur in a great variety of species ranging from humans 32 to invertebrates such as trypanosomes. 33 However, although yeast cells encode a C-terminal tyrosine (Schizosaccharomyces pombe) or a phenylalanine (Saccharomyces cerevisiae), the tyrosination cycle itself does not exist in these species. 34, 35 TTL, the enzyme that catalyses the tubulin tyrosination reaction, adds tyrosine to soluble, detyrosinated tubulin and does not react efficiently with tubulin once it is assembled into microtubules. 29, 31, [36] [37] [38] Less is known about TCP mainly because it has not yet been purified to homogeneity. Indirect evidence indicates that TCP is likely to prefer polymerized substrate and that its binding to microtubules may be required for its function. 37, [39] [40] [41] TCP acts slowly on microtubules, whereas TTL recharges Glutubulin quickly upon release from microtubules 37 (Fig. 1) .
As a consequence of the substrate specificity of TTL and of the kinetics differences of TTL and TCP, tyrosinated tubulin (Tyrtubulin) is the main component of dynamic microtubules, being the dominant tubulin variant in cycling cells in vitro, whereas Glutubulin is a marker of long-lived stable microtubules. 29, 37, [42] [43] [44] [45] Depending on the cell type, these detyrosinated microtubules are ei-ther not detectable or represent a small subpopulation of the cellular microtubules 31 (Fig. 2B) .
Microtubule-depolymerizing agents, which act primarily on dynamic microtubules, proceed principally on the tyrosinated microtubule, whereas microtubule-stabilizing agents such as paclitaxel lead to an enhanced detyrosination of tubulin in microtubules. 37, 40, 46 This enhanced detyrosination, which arises in an almost null background, is easily detectable.
Principle of the assay
We took advantage of this differential repartition of Tyr-and Glu-tubulin in dynamic and stable microtubules, respectively, to design a multiparametric assay allowing the detection of the different types of microtubule poisons. In a 1st step, cells were exposed to drugs. Then, cells were permeabilized in a buffer that preserves intact microtubules but allows the extraction of free tubulin. 47 After fixation, the remaining microtubules were double stained with antibodies specific of Tyr-and Glu-tubulin, followed by fluorescent secondary antibodies. We also added a final DNA staining of the nuclei, using Hoechst reagent. This dye, weakly fluorescent itself in solution, binds specifically to the A-T base pairs in doublestrand DNA, resulting in an increase in fluorescence and a shift in the maximum emission from 500 to 460 nm. 48 We found that Hoechst staining is also a good control of the state of the cell monolayer at the end of the assay and could be an indicator of global effects of the drugs screened on the cell monolayer.
The effects of the different drugs on the microtubular cytoskeleton were finally quantified using a fluorescence microplate reader. Depolymerizing drugs such as colchicine could be identified by a decrease of the fluorescence signal in the Tyrtubulin channel, whereas drugs that stabilize microtubules, such as paclitaxel, could be detected by an increase of the fluorescence signal on the Glu-tubulin channel.
MATERIALS AND METHODS

Materials
Reagents
Bovine serum albumin, EGTA, DMSO, Glycerol (Fluka), Hoechst 33258 (Hoechst), magnesium chloride solution, Pipes, potassium chloride, potassium phosphate monobasic, sodium phosphate dibasic, Triton X-100, and Tween 20 were purchased from Sigma Aldrich (St. Louis, MO). RPMI 1640 medium with Glutamax I, trypsin-EDTA solution, and penicillin-streptomycin solution were from Gibco, Invitrogen (Carlsbad, CA). Sodium chloride was from Carlo Erba Reagents (Rodano, MI, Italy). Fetal bovine serum was from Perbio (Brebières, France).
Antibodies
The monoclonal Tyr-tubulin antibody (clone YL1/2) was a generous gift from Dr. J. V. Kilmartin (MRC, Cambridge, UK). It can also be purchased from Abcam (www.abcam.com). The polyclonal Glu-tubulin antibody (L4) was produced in our laboratory and is also available commercially from Abcys (Paris, France). The cyanine 3 (Cy3)-conjugated goat antirat antibody was from Jackson ImmunoResearch Laboratories (West Grove, PA), and the AlexaFluor 488 (A488)-conjugated goat antirabbit antibody was from Molecular Probes (Invitrogen Corporation, Carlsbad, CA).
Model compounds
Paclitaxel and colchicine were used as bioactive controls and were purchased from Sigma Aldrich. Epothilone B was obtained from Calbiochem (Darmstadt, Germany). Other tested compounds were either purchased from Tocris Cookson (Ellisville, MO) or from Sigma Aldrich. Compounds were dissolved in DMSO so that the final concentration of DMSO on cells did not exceed 0.5% (see the "Results" section).
Cells
HeLa cells were purchased from the American Type Culture Collection (Rockville, MD). They were grown in RPMI 1640 medium with Glutamax supplemented with 10% fetal bovine serum and 1% penicillin-streptomycin in an atmosphere of 5% CO 2 and 95% air at 37°C.
Instrumentation
The screening facility is composed of a TECAN GENESIS 200 workstation as a core component and is completed with a TECAN 9-stacker Carousel BC, a TECAN Te-Shake 2-position plate shaker, a TECAN 6-position Dark Incubator, a KENDRO 42-position Cytomat 2C cell incubator, a TECAN Power Washer 384 with a 96-well wash head, and a BMG FLUOstar Optima plate reader (BMG Labtechnologies, Offenburg, Germany). The platform is controlled using the TECAN Gemini 4.00 and FACTS 4.81 software.
Fluorescence was measured with the FLUOstar Optima plate reader. For Cy3, A488, and Hoechst measurements, we used, respectively, 544-ex, 495-10, and 355-ex filters as excitation filters and 580-12, 520-12, and 460-em filters as emission filters.
Methods
Immunofluorescence procedure for microscopy analysis
Cells grown for 2 days on glass coverslips were incubated 3 min at 37°C with or without OPT buffer (Pipes 80 mM, EGTA 1 mM, MgCl 2 1 mM, triton X-100 0.5%, and glycerol 10%, pH 6.8) and fixed as described in the "Results" section; they were then processed for immunofluorescence as described in Paturle-Lafanechère and others. 46 Fluorescence images were taken using a microscope (Axioskop 50; Zeiss, Oberkochen, Germany) and 100×/1.3 Plan Neofluar objective, a CoolSnap ES charge-coupled device camera (Roper Scientific, Trenton, NJ), and Metaview (Universal Imaging Corp., Sunnyvale, CA) software and were processed using Adobe Photoshop.
Protocol for 96-well format assay
Microplate preparation
HeLa cells were cultured as monolayers. The cells were seeded at 36,000 cells per well of 96-well polystyrene tissue culture plates (reference #655 086; Greiner Bio One, Kremsmuenster, Austria) in 90 µl of medium, using an 8-channel pipettor (Biohit, Helsinki, Finland), and were allowed to grow 24 h.
Drugs addition
The day following microplate preparation, each well was robotically supplemented with 10 µl of RPMI containing test compounds so that the final concentration of test compounds was 25 µM. For bioactive controls, the final concentration was 5 µM for paclitaxel and 2 µM for colchicine. The final concentration of DMSO was 0.5%. After drugs dispense, cells were incubated 2 h at 37°C, 5% CO 2 , in the workstation incubator.
Cell permeabilization, cell fixation
After medium aspiration, cells were permeabilized 10 min with 100 µl of warm OPT buffer and fixed 6 min with 100 µl of methanol.
Microtubule and nuclear staining: basic protocol
After 2 washes with 150 µl of PBS Tween 0.1% (KCl 2.7 mM; KH 2 PO 4 1.5 mM; NaCl 136 mM; Na 2 HPO 4 8 mM; Tween 0.1%; pH 7.4), cells were incubated 2 h at 37°C with a mixture (50 µl per well) of tubulin antibodies: YL1/2 (Tyr-tubulin antibody) and L4 (Glu-tubulin antibody) at a 1:4000 dilution. Cells were rinsed 2 times and then incubated overnight with 200 µl of PBS Tween 0.1%. The next day, cells were incubated 1 h at 37°C with a mixture (50 µl per well) of Cy3 antibody and A488 antibody diluted, respectively, at 1:500 and 1:1000. Then, cells were rinsed 3 times and incubated 1 h with Hoechst (1 µg/ml). After 3 rinses with 200 µl of PBS Tween 0.1%, a 50% glycerol-PBS solution (50 µl) was added into each well. Fluorescence was measured using the FLUOstar Optima microplate reader.
Microtubule and nuclear staining: optimized protocol
After 2 washes with 150 µl of PBS Tween 0.1%, cells were incubated 2 h at 37°C with a mixture (50 µl per well) of tubulin antibodies: YL1/2 and L4 at a 1:4000 dilution. Cells were rinsed 2 times and then incubated overnight with 200 µl of PBS Tween 0.1%. The next day, cells were incubated 1 h at 37°C with a mixture (50 µl per well) of Cy3 antibody and A488 antibody diluted, respectively, at 1:500 and 1:1000 and Hoechst (1 µg/ml). After 3 rinses with 200 µl of PBS Tween 0.1%, a 50% glycerol-PBS solution (50 µl) was added into each well. Fluorescence was measured using the FLUOstar Optima microplate reader.
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Results analysis
Results treatment
Raw data were exported from the microplate reader's software to an Excel file and normalized according to the following procedure. Mean values of DMSO, colchicine, and paclitaxel were calculated for each individual microplate, using intraplate control data points. DMSO and colchicine mean values from Cy3 staining were considered as control (100%) and low (0%) cell Tyr-tubulin content, respectively; DMSO and paclitaxel mean values from A488 staining were considered as low (0%) and high (100%) cell Glu-tubulin content, respectively; DMSO mean values from Hoechst staining were considered as control (100%) cell DNA content. According to that, Cy3, A488, and Hoechst raw data from each tested molecule were converted into percentages of Tyrtubulin, Glu-tubulin, and DNA signals, respectively.
Assay performance
To evaluate the quality of the assay, the Z′ factor was calculated using the following equation according to Zhang and others 49 :
where c+ are the bioactive controls, c-the bioinactive controls, µ the mean, and σ the standard deviation.
RESULTS
Assay miniaturization
Immunofluorescence of the different tubulin isoforms has been widely used in the field of cytoskeleton research, using cells grown on glass coverslips and evaluated by visual analysis under the microscope. However, the miniaturizing of such a procedure in a robust assay, performed in the 96-well plate format and amenable to high-throughput screens using automates and a plate reader, is not trivial. The use of automates instead of humans implies several modifications. The assay also needs to be simplified to accelerate output. Moreover, because of biological variations, cell-based assays are sometimes irreproducible, and detailed method optimizations are unavoidable for their adaptation to highthroughput screening (HTS). To choose the best conditions for the assay, we thus tested different parameters.
Cell permeabilization
The different antibodies that we used stain for both microtubules and free tubulin. Thus, a plate reader will not detect any intensity difference between intact and depolymerized microtubule network (compare Fig. 2A and Fig. 2C ). The addition of a permeabilization step before fixation can solve this problem. The permeabilization buffer we use preserves intact microtubules (compare Fig. 2E and Fig. 2F ) but allows the extraction of free tubulin (compare Fig. 2C and Fig. 2D ). Using this procedure, the effect of depolymerizing agents could be clearly detected by a plate reader (see the final results in Fig. 6 ).
Cell fixation conditions
When immunostaining, the microtubule cytoskeleton cells are commonly fixed for 6 to 10 min with anhydrous methanol at -20°C. However, such cold conditions are not suitable for HTS automate. We thus compared the effect of different fixation conditions (formaldehyde 3.7% or methanol at room temperature) with -20°C methanol fixation on the microtubule network, as observed by immunofluorescence. As shown in Figure 3 , methanol fixation, whatever the temperature, preserves the microtubule network (Fig. 3A, B) . We found that methanol fixation gave better results than formaldehyde fixation (Fig. 3C ) did and thus decided to use methanol at room temperature to fix the cells.
Cell seeding density
We tested the effect of cell seeding density on the dynamic range of the assay. Cells were seeded at different concentrations 1 day before the assay. The next day, the assay was run using colchicine and paclitaxel as bioactive controls and DMSO as bioinactive control (Fig. 4) . Figure 4A shows that the Hoechst signal intensity is a function of the number of cells present in the well, up to 4 10 5 cells/ml. For the different tubulin staining conditions, a plateau is reached for cell concentrations ranging from 3 10 5 to 5 10 5 cells/ml (Fig. 4B,  C) . In this concentration range, there is a clear difference between the signals obtained for untreated cells compared with those treated with drugs (either colchicine or paclitaxel). We thus chose to seed cells at a concentration of 4 10 5 cells/ml. This concentration corresponds to a true seeding number of 3.6 10 5 cells/well (see the "Materials and Methods" section).
Assay optimization
The throughput of an assay can be increased by diminishing the number of steps it contains. We knew that the sequence 1) addition of secondary antibodies, 2) 3 washes, 3) addition of the Hoechst reagent, 4) 3 washes, 5) addition of PBS glycerol, and 6) reading in the plate reader was efficient. To gain 2 steps, we tested if it was possible to add the Hoechst reagent together with the secondary antibodies. Moreover, as the permeabilized cell monolayer is very fragile, such a modification by reducing the number of washing steps (see below) might also improve the quality of the assay. We found that the addition of Hoechst reagent together with the secondary antibodies does not noticeably affect the signal-to-background (S/B) ratio, neither for Tyr-tubulin staining nor for Glu-tubulin staining (not shown). Moreover, this modification of the procedure had no detectable effect on the signal Hoechst itself. We thus adopted this optimized procedure.
DMSO tolerance
DMSO is the most commonly used solvent for chemical libraries. Yet DMSO itself is known to exhibit cytotoxic properties that might induce some false-positive or false-negative results. 50 It is also important to determine the DMSO tolerance of the assay to determine the maximal concentration of the compounds that can be screened. tectable effect on cells was measurable in our experimental conditions.
Assay performance
To evaluate the assay reproducibility and quality, together with its suitability for automation, we ran a series of experiments on the workstation (see description in "Materials and Methods" section). We used known microtubule-destabilizing and -stabilizing agents colchicine 25 (2 µM) and paclitaxel 51 (5 µM) as controls of bioactivity and DMSO as a control of bioinactivity. The quality of the 96-well plate assay was assessed by calculating S/B ratios and Z′ factors according to Zhang and others. 49 For microtubule depolymerizing agents assay (colchicine as control), a DMSO/ colchicine ratio of 5.4 and a Z′ value of 0.66 were obtained (Fig.  6A) . For microtubule-stabilizing agents assay (paclitaxel as control), a paclitaxel/DMSO ratio of 4.1 and a Z′ value of 0.79 were obtained (Fig. 6B) . These Z′ values indicate that this assay is excellent for HTS, for both types of signals.
The run-to-run reproducibility of the assay was assessed by comparing the Z′ factors obtained from separate assays performed at different days. Figure 7 shows the different Z′ values obtained for these different assays. The mean Z′ value was largely above 0.5 for both markers (Fig. 7A, B) . For microtubule depolymerizing assay (Fig. 7A) , 3 experiments out of 9 were qualified by a Z′ value slightly under 0.5 (0.44-0.48). However, for cell-based assays, Z′ factors greater than 0.4 are deemed acceptable. 52 We observed a small drift of the signal, with a slight positive slope from the left to the right of the microplate (Fig. 8A) . However, the resulting greater dispersion of the points has no major consequence on the Z′ factor. This slope was more accentuated for the Cy3 channel (Tyr-tubulin channel) than for the A488 channel (Glu-tubulin channel) and could explain the lesser reproducibility of this part of the assay. We tested separately the different steps of the procedure and found that the slope resulted from a lack of homogeneity of the washing steps, due to an inhomogeneous aspiration by the microplate washer. This is demonstrated by the fact that the slope is reverted when the microplate is manually rotated, only for the washing steps, so that the H12 well is transposed to the opposite corner (A1 well; Fig. 8B ). This result underlies the importance of the quality of microplate washers for such cell-based assays.
Assay sensitivity
Screening campaigns using cell-based assays are usually run using a rather elevated concentration of the tested compounds (10 to 50 µM). However, to evaluate the sensitivity of the assay we developed, we tested the effect of different concentrations of colchicine and paclitaxel on the fluorescence intensity measured by the microplate reader. As shown in Figure 9A , a depolymerizing effect of colchicine could be detected for a concentration of 0.1 µM. The paclitaxel effect is very strong, and we could detect an effect at 0.01 µM (Fig. 9B) . 
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Validation of the assay with model compounds
The 96-well plate assay was evaluated by testing a set of known microtubule poisons. This includes about 10 drugs that have been described to show a microtubule depolymerizing effect and 3 microtubule-stabilizing agents (paclitaxel, docetaxel, and epothilone B). All of these compounds were randomly distributed into a microplate. The other wells of the microplate were filled with chemicals known for their activity on other biological targets such as proteins involved in actin dynamics, cell cycle regulation, protein synthesis, and so forth. All molecules were incubated 2 h with HeLa cells and tested at a final concentration of 25 µM. The results of this experiment are summarized in Table 1 .
None of the agents known to target other systems than the microtubular system, including agents directed on the actin cytoskeleton, were found to be bioactive in our assay. Known microtubule-destabilizing agents such as colchicine, 25 nocodazole, 25 combretastatin, 25, 53 and podophyllotoxin 54 were easily detected in the Tyr-tubulin Cy3 channel. Paclitaxel, docetaxel, and epothilone B were also scored as bioactive in the Glu-tubulin A488 channel.
However, several other agents known to show some microtubule-depolymerizing effects were not detected in this assay. These include Vinca alkaloids (vinblastine and vincristine), 25 benomyl, 55 griseofulvin, 56 noscapine, 57, 58 and BAPTA-AM. 59 Careful examination of the mode and field of action of these different substances can clearly explain why the assay failed to detect any effect of these substances.
Vinca alkaloids have been reported not only to depolymerize microtubules but also to give rise to stable paracrystallin bundles of protofilamentous tubulin, in a time and concentration dependent manner, both in cells 46 and in vitro. 60 Recently, the tubulin-binding site of vinblastine has been elucidated. 61 Vinblastine's interdimer location gives the structural basis to this peculiar effect of vinblastine on tubulin assembly. 61 We have checked that in our ex-perimental conditions, vinblastine effectively induces tubulin paracrystals. As shown in Figure 10A , these stable paracrystals effectively occur after 2 h of incubation with 25 µM vinblastine. They are brightly stained with Tyr-tubulin antibody. Clearly, the fluorescence reader could not allow any distinction between the signal given by such paracrystals (Fig. 10A) and a normal bright microtubule network (Fig. 10C) . We have tested if shorter incubation of the cells with vinblastine, or incubation with lower concentration, induced a depolymerization that could be detected by the fluorescence reader ( Fig. 11) . For a concentration of 0.25 µM, the depolymerizing effect of vinblastine was always detectable, however long the duration of incubation. A depolymerizing effect of 25 µM vinblastine could be detected for 15-and 30-min incubation times. It was no longer detectable after 120 min of incubation because of tubulin paracrystals formation.
Benomyl as well as griseofulvin are antifungal drugs, known to interact with fungal tubulin. Although they have been shown to inhibit mammalian tubulin polymerization in vitro, their effects on interphase microtubules in HeLa cells are hardly detectable for such concentration and incubation duration. 56, 62, 63 The opium alkaloid noscapine shares some structural similarities with known microtubule assembly inhibitors such as colchicine and podophyllotoxin. It has been shown to bind to tubulin, to alter in vitro microtubule assembly, and to arrest cells in mitosis, after 24 h of treatment. 58 However, even at high doses and for a long time of incubation, a noscapine effect on the interphase microtubule network could not be detected. 57 Actually, we have checked by immunofluorescence visualization that no detectable effect on HeLa interphase microtubule could be found after 2 h of incubation with 25 µM of noscapine (data not shown).
A calcium-independent microtubular disassembly induced by BAPTA-AM has been described recently. 59 This potent depolymerizing effect is observed for many cell types, with the exception of HeLa cells (Yasmina Saoudi, personal communication). This obviously explains why the present assay failed to detect any effect of BAPTA-AM.
Hoechst staining, which allows the measurement of DNA in the nuclei, was initially introduced in our assay to give an indirect estimation of the integrity of the cell monolayer. However, we found that this marker, in combination with the 2 other markers, can give additional information. For example, cells treated with daunorubicin showed normal fluorescence intensity in Tyr-and Glu-tubulin channels together with a decrease of fluorescence intensity in the Hoechst channel. This decrease could not be the result of the uneven detachment of the cells as the Tyr-and Glutubulin signals are normal. In fact, daunorubicin is an anthracycline antibiotic that is used in cancer chemotherapy. 64 It has the property to intercalate into the double strand of DNA. 65 The decrease observed in the Hoechst channel can thus be interpreted as the result of the competitive action of daunorubicin. Although the generalization of this single data should be done cautiously, this result indicates that our assay can also detect DNA intercalating agents, although it was not designed for that specific purpose.
DISCUSSION
Here, we describe a cell-based assay for microtubule poisons. When searching for therapeutic agents, cell-based assays are particularly valuable compared with cell-free assays because they select not only for activity against a particular molecular target but also for other desirable properties, such as the ability to permeate cells and to retain activity in tissue culture medium and in cells. 66 First-generation tubulin anticancer drugs were discovered via inhibition of cancer cell cultures 67 and animal studies, 68 whereas 2nd-generation compounds were mainly developed by direct screening for inhibition of tubulin assembly in vitro. Thus, the systematic screening of chemical libraries for antimicrotubule agents relies either on a rather unspecific cell-based assay (i.e., cytotoxicity assays) or on a specific but in vitro biochemical assay. Compounds selected by such in vitro assays further need to reach their cellular target, and only this one, by crossing the plasma membrane and by avoiding rapid degradation. Although other cell-based screens, suitable for high-throughput approaches, have been described for agents that cause mitotic arrest, 66,69 a highthroughput assay probing the microtubule polymerization status has not been described to our knowledge.
The main qualities required for a good screening assay are high information content combined with high throughput. The assay we proposed is simple, robust, and multiparametric. It does not require a costly automated cellular imaging and analysis device, such as those designed for high-content screening. It allows the detection, in a single screening campaign, of both agents able to depolymerize the microtubular cytoskeleton and agents that enhance microtubule detyrosination. These latter compounds could be either direct microtubule stabilizers, such as paclitaxel, or compounds regulating the activity of the tubulin tyrosination enzymes. For example, TTL inhibition or TCP activation could result in an enhanced detyrosination of cell microtubules. Such pharmacological agents have not been described yet. However, the final selection of true microtubule-stabilizing agents could be done by secondary assays. These assays could include analysis of the effect of these agents on in vitro tubulin assembly or on cellular microtubule cold stability. 47 Although we have found that this assay is specific of the microtubule network, we could not exclude that, as for microtubule stabilization, microtubule disassembly could result from a direct action of the compounds on tubulin or from an indirect action on other cellular components. Again, the final selection of true microtubule-destabilizing agents would require additional assays, such as analysis of the effect of the compounds on in vitro tubulin assembly.
Microtubule dynamics are highly regulated during the cell cycle by endogenous cellular regulators. The proposed assay is a mean to search not only agents that interact with microtubules but also those that modify microtubule dynamics by other mechanisms, for example, by interacting with microtubule effectors. In the context of the fight against cancer, such compounds, acting on different targets, could be of great interest.
In addition to the 3 measured parameters, we found that the comparative analysis of the results provided supplementary information. The analysis of the daunorubicin effects is an example (see above). Another example could be a compound that induces a decrease of the Tyr-tubulin signal together with a decrease of the Hoechst staining. Such a combinatorial effect could derive from a global effect on cell adhesion, leading to the detachment of cells rather than a true microtubule-depolymerizing effect.
The present assay failed to detect Vinca alkaloid agents because of the formation of bright tubulin paracrystals induced by an elevated concentration of these agents. However, we showed that the assay was able to detect such agents when they were tested at lower concentrations. Other depolymerizing drugs, such as maytansine, rhizoxin, or dolastatin 70 that bind to the Vinca domain of tubulin but do not induce paracrystals, should be detected by the assay.
We have used HeLa cells to set up this assay because of their human origin, their epithelial status, and their easy culture. However, this assay could be easily adapted to other cell lines such as cell lines resistant to known microtubule poisons.
In conclusion, the assay described in this article should greatly facilitate the discovery and development of novel microtubule poisons and their characterization in the context of living cells. Moreover, in the context of drug discovery, profiling technologies could be useful in measuring both drug action on a desired target in the cellular milieu and drug actions on other targets. 71 The microtubular cytoskeleton components have been identified as toxicity-modulating hot spots. 72 Thus, the cell-based assay described here could also find other applications in the context of drug profiling.
